- Procter & Gamble Health Ltd
-
PGHL Stock View
(NSE)
4,405.85
7,313.44
Proj. ROE (%)
-
Proj. P/E (x)
-
Proj EV / EBITDA (x)
-
Proj. P/BV (x)
-
Proj. Revenue ( Cr.)
-
Result Express
The average score for Procter & Gamble Health Ltd stands at 8 against 7, three months back.
Procter & Gamble Health Limited is an India-based company that is primarily engaged in the manufacturing of pharmaceutical products. The Company provides healthcare products. It is involved in manufacturing and marketing over-the-counter vitamins, minerals, and supplements products for a healthy lifestyle. The Company offers brands, including Cosome, Neurobion, Livogen, SevenSeas, Evion, Polybion and Nasivion. The Company’s geographical segments include India and outside India. It has its manufacturing facility situated at Usgaon, Goa. The Company has a sterile facility with a capacity of approximately 260 Mio ampoules per annum and a soft gel manufacturing site with a capacity of over 744 Mio capsules per annum. Its manufacturing site also exports to approximately 13 countries within P&G Personal Healthcare International.
Disclaimer : All estimates (1 year forward) are based on Consensus View provided by Refinitiv.
Technical Data
-
4,252.41
-
4,283.82
-
4,667.47
3,901.05
5,851.75
Street View :-
Bearish
